Nobel Biocare

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations – from single-tooth to fully edentulous indications. The company’s portfolio offers: - Dental implant systems - Individualized prosthetics and CAD/CAM systems - Treatment planning - Guided surgery solutions - Biomaterials Our goal is to empower dental professionals to give quality of life back to their patients. This philosophy is built on over 60 years of continuous innovation, all stemming from Per-Ingvar Brånemark’s ground-breaking discovery of osseointegration in 1952. Since then, we’ve helped our customers treat millions of patients. Privacy policy: http://bit.ly/2T1atvE Disclaimer: We welcome and encourage your comments and look forward to engaging with you. While you're here, we request that you follow a few basic guidelines: - If you wish to report product complaints, side effects or adverse events to us or have Customer Support related questions or inquiries, please contact Post Market Surveillance (PMS) team at productcomplaint@nobelbiocare.com.. Nobel Biocare will follow its normal process in referring any such reports to the appropriate department and, therefore, reserves the right to remove any such complaints or reports from this site. - To ensure that our page provides meaningful interactions, please keep comments on topic whenever possible. - Postings that are considered abusive, or that infringe copyright or intellectual property rights of others will be removed at our discretion. - We reserve the right to remove a topic or comment at our discretion. - The collection, storage, use, disclosure, retention and destruction of data on this page, including any personal data, are all subject as applicable, to Nobel Biocare’s Terms of Use and Privacy Policy.

Neodent

Neodent is a global brand available in more than 90 countries, founded by a dentist for dentists with the purpose of changing patients’ lives. With a legacy of 30 years focused on ease of use, Neodent Dental Implant Systems focus on progressive treatment concepts, such as immediacy with modern and reliable solutions to enable therapy access and affordability for creating new smiles every day.

Terumo Medical Corporation

Our Promise At Terumo, everything starts with our unwavering commitment to patients. Listening sincerely to their needs and deeply understanding their hopes and aspirations, we boldly pursue innovative ways to help enhance the lives of patients around the world. Our Promise Story Terumo was founded by a group of physicians and scientists to support the lives of people. Ever since then, we have been doing all we can to advance healthcare and enhance patients’ quality of life. This mindset, expressed in our Group Mission, “Contributing to Society through Healthcare,” drives our continuous transformation to do even more. We will listen sincerely to patients’ needs and deepen our understanding of their hopes and aspirations to discover what will be truly beneficial for them. We will work more closely with healthcare professionals and partners pursuing innovative solutions and ways to advance patient care together. And we will continue to expand our activities and take on new challenges with the thoughts and feelings of patients in mind. We are driven by our desire to help improve patients’ lives. By putting this unwavering commitment into action, we will realize a better future for healthcare and patients.

OrbusNeich Medical Company Ltd.

OrbusNeich is a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, OrbusNeich sells products to over 70 countries and regions worldwide, and it is also the only PCI balloon manufacturer headquartered in China that ranked among the top 6 players in all major overseas PCI balloon markets including Japan, Europe and the U.S. According to an industry research report, in terms of sales volume of PCI balloons in 2021, OrbusNeich held an over 50% share of the PCI balloon market in Hong Kong, and ranked No. 2 in Japan, No. 4 in Europe, No. 6 in the PRC and No. 6 in the U.S . In addition, in terms of sales volume of PTA balloons in 2021, it ranked No. 3 in Japan and No. 4 in the U.S. In addition to PCI/PTA balloons, it also specializes in coronary stent products and is actively expanding into neuro vascular intervention and structural heart disease areas. OrbusNeich owns more than 180 granted patents globally. Its in-house R&D team has over twenty years of product development experience and has developed proprietary, world leading technologies, including its Scoreflex NC product, the world’s smallest profile non-compliant scoring balloon; its proprietary “drug plus antibody” COMBO dual therapy stent; and its JADE non-compliant peripheral balloon, the first and only non-compliant over-the-wire PTA balloon approved by the FDA that is compatible with all guidewire systems in the U.S. OrbusNeich is listed on the Main Board of The Stock Exchange of Hong Kong Limited (“HKEX”), under the stock code 6929. For more information and news, visit http://www.orbusneich.com/ or follow us on Twitter @OrbusNeich (Last updated on 23rd Dec 2022)

terumo europe

Terumo Europe is a core player in the EMEA healthcare market by providing best-in-class quality medical products and services. We are a strong actor of the Terumo Group by contributing to innovation and sustainable growth. Terumo Europe produces, distributes, markets, and sells a vast range of medical devices in five main business units: Interventional Systems, Pharmaceutical Solutions, Hospital Care Solutions, Cardiovascular and Life Care Solutions. Our headquarters are located in Leuven (Belgium). Terumo Europe committed to cultivating a globally diverse, equitable and inclusive culture. We empower everyone to bring their authentic self to work, which we believe leads to innovation that addresses the diverse healthcare needs of global society.